1. Market Research
  2. > Healthcare
  3. > Medical Device
  4. > Diagnostic Imaging Market Trends
  5. > MediPoint: Magnetic Resonance Imaging Systems - APAC Analysis and Market Forecasts

MediPoint: Magnetic Resonance Imaging Systems - APAC Analysis and Market Forecasts

Summary

The global magnetic resonance imaging (MRI) market is a shifting, capital equipment market that is saturated with numerous players developing innovative technologies. Given their impressive safety and efficacy as well as non-invasive nature, MRI systems have seen continued adoption since they were first introduced to the healthcare market. Rapid advances in the field imaging along with the development of MRI safe technologies have greatly expanded the potential of therapeutic applications.

All MRI markets in Japan are expected to experience growth through 2020, including low-field systems, which are declining in many other countries globally. All MRI market segments will experience growth in China during the forecast period, although low-field systems will grow at a small CAGR of 1.0%. In India, the low-field strength MRI market segment will decline slightly at a negative CAGR of 0.6% through 2020,

Scope

- An overview of Magnetic Resonance Imaging Systems, which includes epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines.
- Annualized the APAC Magnetic Resonance Imaging Systems market revenue and future forecasts from 2011 to 2013, forecast for 7 years to 2020.
- Investigation of current and future market competition for Magnetic Resonance Imaging Systems.
- Insightful review of the key industry drivers, restraints and challenges as well as predicted impact of key events.
- Competitor assessment including device approval analysis and device sales forecasts.
- Marketed and pipeline product profiles covering efficiency, safety, clinical study details, device approvals, product positioning and device sales forecast.
- Analysis of unmet needs within the market and opportunities for future players.
- Technology trends evaluation to assess strength of pipeline.
- An overview of all devices in development including clinical study details, design and material selection considerations, efficacy reports, and device approval timelines.
- Company profiles including business description, financial overview and SWOT analysis.
- Coverage of key market players.
- Strategic assessment of the Magnetic Resonance Imaging Systems sector through market impact analysis, future market scenario and company analysis.
- Direct quotes from Key Opinion Leaders (KOL) as well as doctors

Reasons to buy

- Understand the trends shaping and driving the APAC Magnetic Resonance Imaging Systems market.
- Realize device preferences of physicians who have performed the tests already.
- Access market sizing, forecasts and quantified growth opportunities in the APAC Magnetic Resonance Imaging Systems market through 2018.
- Quantify candidate patient populations to better design product pricing & launch plans.
- Drive revenues, formulate effective sales and marketing strategies and gain in-depth understanding of the competitive landscape.
- Perform benchmarking analysis of growth opportunities against currently marketed products.
- Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition.
- Take a comprehensive look at the market’s device pipeline and identify promising, paradigm-shifting products.
- Create an effective counter-strategy to gain a competitive advantage against those currently in the market.
- Organize your sales and marketing efforts by identifying the market categories and segments that present the best opportunities for growth.
- What’s the next big thing in the APAC Magnetic Resonance Imaging Systems market landscape? Identify, understand and capitalize.

Table Of Contents

MediPoint: Magnetic Resonance Imaging Systems - APAC Analysis and Market Forecasts
1 Table of Contents
1 Table of Contents 6
1.1 List of Tables 14
1.2 List of Figures 18
2 Introduction 19
2.1 Catalyst 20
2.2 Related Reports 20
3 Industry Overview 21
3.1 Overview of MRI Technology 21
3.2 System Overview 22
3.2.1 Pre-Polarizing MRI Systems 23
3.2.2 Diffusion MRI 24
3.2.3 Apparent Diffusion Coefficient 24
3.3 Applications of Technology 25
3.4 Clinical Indications for MRI scans 25
3.5 Procedure Trends 27
3.5.1 Product Lifecycle 27
3.6 Advantages and Disadvantages of Technology 29
3.6.1 Overview 29
3.6.2 MRI Technology SWOT Analysis 29
3.6.3 Claustrophobia Issues with MRI Systems 30
3.6.4 Magnetic Resonance Imaging vs. Computed Tomography 31
3.7 Market Access 32
3.7.1 Product Life Cycle 32
3.7.2 Purchasing Decisions 33
3.7.3 Role of Group Purchasing Organizations 34
3.8 Regulatory Process 36
3.8.1 Japan 36
3.8.2 China 37
3.8.3 India 37
3.9 Current MRI Reimbursement Trends 39
3.9.1 Japan 39
3.9.2 China 39
3.9.3 India 40
3.10 Procedure Trends 41
3.10.1 Neurology 41
3.10.2 Extremity MRI 42
3.10.3 PET/MRI 43
3.10.4 Asia-Pacific 43
3.10.5 Magnetic Resonance Angiography 44
3.10.6 Magnetic Resonance Spectroscopy 44
3.10.7 Hours of Operation 44
3.10.8 Regulatory Issues/Recalls 45
3.11 Economic Impact 45
3.11.1 Direct Costs 46
3.11.2 Pricing of MRI Systems 46
4 Unmet Needs 50
4.1 Overview 50
4.2 Storing and Managing Patient Data 51
4.3 Multiparametric MRI 52
4.4 Quieter Systems for Improved Patient Comfort 53
4.5 Improved Software to Support Advanced Image Acquisition Hardware 53
4.6 Faster Throughput 56
4.7 Improvements in Patient Comfort 57
5 Market Opportunity Analysis 58
5.1 Overview 58
5.2 Standardization of Scans 59
5.3 Increased Adoption of MRI Throughout the Hospital 60
5.4 Cardiac MRI on the Rise 60
5.5 High-Field MRI in Developing Brains 62
5.6 Permanent Magnets Still Desirable Where Power Unreliable 63
5.7 Imaging Brain Tumors 64
5.8 Cryogen-Free Cooling Systems 64
5.9 Additional Scanners for Outpatient Exams 65
5.10 Breast and Prostate Cancer MRI 66
5.11 Whole-Body MRI for Cancer 67
5.12 Cloud Computing on the Rise 67
5.13 New MRI Technique to Speed Up Diagnosis for Traumatic Brain Injury 68
6 Market Drivers and Barriers 69
6.1 Overview 69
6.2 Driver: Improved Imaging Capabilities of Higher Field Strength 69
6.3 Driver: Low-Quality Images from Older Machines 71
6.4 Driver: High Average Age of MRI Systems 71
6.5 Driver: Difficulty of Achieving Homogenous Signals with Older Systems 72
6.6 Barrier: Fewer Resources for Training on Machines 72
6.7 Barrier: Economic Pressure Reduces New Systems Volume 73
6.8 Barrier: Misuse of Systems 74
6.9 Barrier: Overuse of MRI Systems 75
6.10 Barrier: ISOs a Cheaper Alternative to Service or New Sales from OEM 76
6.11 Barrier: Supeconducting MRI Magnet Producers 77
6.12 Barrier: Uneven Reimbursement for MRI Procedures 78
7 Competitive Assessment 79
7.1 Full Profiles for Key Products 79
7.1.1 Oasis (Hitachi) 79
7.1.2 Echelon Oval (Hitachi) 80
7.1.3 Discovery MR750w (GE Healthcare) 81
7.1.4 Optima MR360 Advance (GE Healthcare) 82
7.1.5 Optima MR450w (GE Healthcare) 83
7.1.6 Signa HDxt (GE Healthcare) 84
7.1.7 Vantage Titen (Philips Healthcare) 85
7.1.8 Ingenia (Philips Healthcare) 86
7.1.9 Achieva TX (Philips Healthcare) 87
7.1.10 Magnetom Aera (Siemens Healthcare) 88
7.1.11 Magnetom C! (Siemens Healthcare) 89
7.1.12 Magnetom Spectra (Siemens Healthcare) 90
7.1.13 NSM-S15 (Neusoft Medical Systems) 91
7.2 Classification Based on Field Strength 92
7.2.1 Low-Field MRI Systems 92
7.2.2 Mid-Field MRI Systems 94
7.2.3 High-Field MRI Systems 96
8 Pipeline Assessment 98
8.1 11.7T MRI System (Neurospin) 98
8.1.1 Overview 98
8.1.2 SWOT 98
8.2 Aurora PET/MRI System (Aurora Imaging Technology) 98
8.2.1 Overview 98
8.2.2 SWOT 99
8.3 Neona (Time Medical) 99
8.3.1 Overview 99
8.3.2 SWOT 99
8.4 GE 7.0T MRI Scanner (GE Healthcare) 100
8.4.1 Overview 100
8.4.2 SWOT 100
8.5 Signa PET/MRI (GE Healthcare) 100
8.5.1 Overview 100
8.5.2 SWOT 101
9 Current and Future Players 102
9.1 Overview 102
9.2 Aurora Imaging 102
9.2.1 Overview 102
9.2.2 Portfolio Assessment 103
9.2.3 SWOT Analysis 103
9.3 China Resources Wandong Medical Equipment 104
9.3.1 Overview 104
9.3.2 Portfolio Assessment 104
9.3.3 SWOT Analysis 105
9.4 Esaote S.p.A. 105
9.4.1 Overview 105
9.4.2 Portfolio Assessment 106
9.4.3 SWOT Analysis 106
9.5 Fonar Corporation 106
9.5.1 Overview 106
9.5.2 Portfolio Assessment 107
9.5.3 SWOT Analysis 107
9.6 GE Healthcare 108
9.6.1 Overview 108
9.6.2 Portfolio Assessment 108
9.6.3 SWOT Analysis 110
9.7 Hitachi Medical Corporation 110
9.7.1 Overview 110
9.7.2 Portfolio Assessment 111
9.7.3 SWOT Analysis 112
9.8 Hologic 112
9.8.1 Overview 112
9.8.2 Portfolio Assessment 113
9.8.3 SWOT Analysis 113
9.9 Mindray 114
9.9.1 Overview 114
9.9.2 Portfolio Assessment 114
9.9.3 SWOT Analysis 115
9.10 Neusoft Medical 115
9.10.1 Overview 115
9.10.2 Portfolio Assessment 116
9.10.3 SWOT Analysis 116
9.11 Ningbo Xingaoyi Medical 116
9.11.1 Overview 116
9.11.2 Portfolio Assessment 117
9.11.3 SWOT Analysis 117
9.12 Philips Healthcare 118
9.12.1 Overview 118
9.12.2 Portfolio Assessment 118
9.12.3 SWOT Analysis 120
9.13 Siemens Healthcare 120
9.13.1 Overview 120
9.13.2 Portfolio Assessment 121
9.13.3 SWOT Analysis 123
9.14 Sina Healthcare 123
9.14.1 Overview 123
9.14.2 Portfolio Assessment 124
9.14.3 SWOT Analysis 125
9.15 Time Medical 125
9.15.1 Overview 125
9.15.2 Portfolio Assessment 126
9.15.3 SWOT Analysis 127
9.16 Toshiba Medical Systems Corporation 127
9.16.1 Overview 127
9.16.2 Portfolio Assessment 128
9.16.3 SWOT Analysis 128
10 Stategic Competitive Assessment 129
10.1 Company Market Share 129
10.1.1 APAC 129
10.1.2 Japan 131
10.1.3 China 132
10.1.4 India 133
11 Market Outlooks by Market Segment 135
11.1 Market Segment by Country 135
11.1.1 Japan 135
11.1.2 China 137
11.1.3 India 138
12 Market Outlooks by Geography 139
12.1 APAC 139
12.1.1 APAC Market Share by Country 139
12.1.2 APAC Market Value by Market Segment 141
12.2 Japan 142
12.2.1 Market Value by Market Segment 142
12.2.2 Installed Base of MRI Systems 143
12.3 China 144
12.3.1 Market Value by Market Segment 144
12.3.2 Installed Base of MRI Systems 145
12.4 India 146
12.4.1 Market Value by Market Segment 146
12.4.2 Installed Base of MRI Systems 147
13 Appendix 149
13.1 Bibliography 149
13.2 Abbreviations 155
13.3 Report Methodology 158
13.3.1 Overview 158
13.3.2 Coverage 158
13.3.3 Secondary Research 158
13.4 Forecasting Methodology 159
13.5 Primary Research — Key Opinion Leaders 160
13.6 Primary Research — Physician and Industry Overviews 160
13.6.1 Expert Panel Validation 163
13.7 Physicians and Experts Included in this Study 163
13.8 About the Authors 165
13.8.1 Analysts 165
13.8.2 Global Head of Healthcare 165
13.9 About MediPoint 166
13.10 About GlobalData 166
13.11 Disclaimer 166

1.1 List of Tables
Table 1: MRI Procedure Targets 26
Table 2: Indications for an Immediate Emergency MRI 27
Table 3: Advantages and Disadvantages of MRI 29
Table 4: Magnetic Resonance Imaging Technology SWOT Analysis 30
Table 5: Selected Group Purchasing Organizations in the US and EU 35
Table 6: Japan Average Selling Price by Market Segment (2011-2020), $m 46
Table 7: China Average Selling Price by Market Segment (2011-2020), $m 47
Table 8: India Average Selling Price by Market Segment (2011-2020), $m 48
Table 9: MRI Applications and Future Market Potential 59
Table 10: SWOT Analysis — Oasis 80
Table 11: SWOT Analysis — Echelon Oval 81
Table 12: SWOT Analysis — Discovery MR750w 82
Table 13: SWOT Analysis — Optima MR360 Advance 83
Table 14: SWOT Analysis — Optima MR450w 84
Table 15: SWOT Analysis — Signa HDxt 85
Table 16: SWOT Analysis — Vantage Titen 86
Table 17: SWOT Analysis — Ingenia 87
Table 18: SWOT Analysis — Achieva TX 88
Table 19: SWOT Analysis — Magnetom Aera 89
Table 20: SWOT Analysis — Magnetom C! 90
Table 21: SWOT Analysis — Magnetom Spectra 91
Table 22: SWOT Analysis — NSM-S15 91
Table 23: SWOT Analysis — Low-Field MRI Systems 92
Table 24: Low-Field MRI Systems 93
Table 25: SWOT Analysis — Mid-Field MRI Systems 94
Table 26: Mid-Field MRI Systems 95
Table 27: SWOT Analysis — High-Field MRI Systems 96
Table 28: High-Field MRI Systems 97
Table 29: SWOT Analysis — 11.7T MRI (Neurospin) 98
Table 30: SWOT Analysis — Aurora PET/MRI System (Aurora Imaging Technology) 99
Table 31: SWOT Analysis — Neona (Time Medical) 99
Table 32: SWOT Analysis — 7.0T MRI Scanner (GE Healthcare) 100
Table 33: SWOT Analysis — Signa PET/MR (GE Healthcare) 101
Table 34: Company Profile — Aurora Imaging 103
Table 35: Aurora Imaging, MRI System Device Portfolio 103
Table 36: SWOT Analysis — Aurora Imaging 103
Table 37: Company Profile — China Resources Wandong Medical Equipment 104
Table 38: China Resources Wandong Medical Equipment, MRI System Device Portfolio 104
Table 39: SWOT Analysis — China Resources Wandong Medical Equipment 105
Table 40: Company Profile — Esaote S.p.A. 105
Table 41: Esaote S.p.A., MRI System Device Portfolio 106
Table 42: SWOT Analysis — Esaote S.p.A. 106
Table 43: Company Profile — Fonar Corporation 107
Table 44: Fonar Corporation, MRI System Device Portfolio 107
Table 45: SWOT Analysis — Fonar Corporation 107
Table 46: Company Profile — GE Healthcare 108
Table 47: GE Healthcare, MRI System Device Portfolio 109
Table 48: SWOT Analysis — GE Healthcare 110
Table 49: Company Profile — Hitachi Medical Corporation 111
Table 50: Hitachi Medical Corporation, MRI System Device Portfolio 111
Table 51: SWOT Analysis — Hitachi Medical 112
Table 52: Company Profile — Hologic 113
Table 53: SWOT Analysis — Hologic 113
Table 54: Company Profile — Mindray 114
Table 55: Mindray, MRI System Device Portfolio 114
Table 56: SWOT Analysis — Mindray 115
Table 57: Company Profile — Neusoft Medical 115
Table 58: Neusoft Medical, MRI System Device Portfolio 116
Table 59: SWOT Analysis — Neusoft Medical 116
Table 60: Company Profile — Ningbo Xingaoyi Medical 117
Table 61: Ningbo Xingaoyi Magnetism, MRI System Device Portfolio 117
Table 62: SWOT Analysis — Ningbo Xingaoyi Magnetism 117
Table 63: Company Profile — Philips Healthcare 118
Table 64: Philips Healthcare, MRI System Device Portfolio 119
Table 65: SWOT Analysis — Philips Healthcare 120
Table 66: Company Profile — Siemens Healthcare 121
Table 67: Siemens Healthcare, MRI System Device Portfolio 122
Table 68: SWOT Analysis — Siemens Healthcare 123
Table 69: Company Profile — Sina Healthcare 124
Table 70: Sina Healthcare, MRI System Device Portfolio 125
Table 71: SWOT Analysis — Sina Healthcare 125
Table 72: Company Profile — Time Medical 126
Table 73: Time Medical, MRI System Device Portfolio 126
Table 74: SWOT Analysis — Time Medical 127
Table 75: Company Profile — Toshiba 127
Table 76: Toshiba, MRI System Device Portfolio 128
Table 77: SWOT Analysis — Toshiba 128
Table 78: APAC Market Sales for MRI Systems (2012) 130
Table 79: Japan Market Sales for MRI Systems (2012) 131
Table 80: China Market Sales for MRI Systems (2012) 132
Table 81: India Market Sales for MRI Systems (2012) 133
Table 82: Japan Market Segment, 2012 and 2020 135
Table 83: China Market Segment, 2012 and 2020 137
Table 84: India Market Segment, 2012 and 2020 138
Table 85: APAC Market by Country, 2012 and 2020 139
Table 86: APAC Market Value by Market Segment for MRI Systems (2011-2020), $m 141
Table 87: Japan Market Value Forecast by Market Segment (2011-2020), $m 142
Table 88: Japan Installed Base of MRI Systems (2011-2020) 143
Table 89: China Market Value Forecast by Market Segment (2011-2020), $m 144
Table 90: China Installed Base of MRI Systems (2011-2020) 145
Table 91: India Market Value Forecast by Market Segment (2011-2020), $m 146
Table 92: India Installed Base of MRI Systems (2011-2020) 147
Table 93: Primary Research Interviews Completed by Country 161
Table 94: Primary Research Interviews Completed by Designation 162

1.2 List of Figures
Figure 1: Japan Average Selling Price by Market Segment 47
Figure 2: China Average Selling Price by Market Segment 48
Figure 3: India Average Selling Price by Market Segment 49
Figure 4: Average Age for Magnetic Resonance Imaging Machines in 5EU in 2013 72
Figure 5: APAC Market Share for MRI Systems (2012) 130
Figure 6: Japan Market Share for MRI Systems (2012) 131
Figure 7: China Market Share for MRI Systems (2012) 132
Figure 8: India Market Share for MRI Systems (2012) 134
Figure 9: Japan Market Segment, 2012 and 2020 136
Figure 10: China Market Segment, 2012 and 2020 137
Figure 11: India Market Segment, 2012 and 2020 138
Figure 12: APAC Market by Country, 2012 and 2020 140
Figure 13: APAC Market Value Forecast by Market Segment for MRI Systems (2011-2020), $m 141
Figure 14: Japan Market Value Forecast by Market Segment (2011-2020), $m 143
Figure 15: Japan Installed Base of MRI Systems (2011-2020) 144
Figure 16: China Market Value Forecast by Market Segment (2011-2020), $m 145
Figure 17: China Installed Base of MRI Systems (2011-2020) 146
Figure 18: India Market Value Forecast by Market Segment (2011-2020), $m 147
Figure 19: India Installed Base of MRI Systems (2011-2020) 148
Figure 20: Primary Research Interviews Completed by Country 161
Figure 21: Primary Research Interviews Completed by Designation 162

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Medical Magnetic Resonance Imaging (MRI): Technologies and Global Markets

Medical Magnetic Resonance Imaging (MRI): Technologies and Global Markets

  • $ 6650
  • Industry report
  • September 2016
  • by BCC Research

This BCC Research report measures, forecasts and segments the global magnetic resonance imaging (MRI) systems market by type of structure, field strength, application, technique, and region. Forecasts ...

Small Animal Imaging Market by Modality, Reagent - Global forecast to 2021

Small Animal Imaging Market by Modality, Reagent - Global forecast to 2021

  • $ 5650
  • Industry report
  • September 2016
  • by MarketsandMarkets

The global small animal imaging market is estimated to grow at a high CAGR of 6.2% during 2016-2021; and is projected to be valued at USD 910.4 million by 2021. Market growth in the global small animal ...

Contrast Media/Contrast Agent Market by Type, Procedure & Application - Global Forecasts to 2021

Contrast Media/Contrast Agent Market by Type, Procedure & Application - Global Forecasts to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global contrast media/contrast agents market is projected to reach USD 5.44 billion by 2021 from USD 4.46 billion in 2016 growing at a CAGR of 4.1% during the forecast period. The contrast media/contrast ...

Global Imaging Agents Industry

September 2016 $ 4950

Global Superconductors Industry

October 2016 $ 4950

ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.